![]() |
市场调查报告书
商品编码
1889226
宠物焦虑解决方案市场预测至2032年:按产品、宠物类型、分销管道、最终用户和地区分類的全球分析Pet Anxiety Solutions Market Forecasts to 2032 - Global Analysis By Product (Medications, Behavioral Training Products, Supplements, Calming Devices and Other Products), Pet Type, Distribution Channel, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球宠物焦虑解决方案市场价值将达到 20 亿美元,到 2032 年将达到 31 亿美元,在预测期内的复合年增长率为 6.3%。
宠物焦虑解决方案涵盖一系列旨在缓解动物(尤其是犬猫等伴侣动物)压力、恐惧和紧张行为的产品、疗法和介入。这些解决方案包括镇静补充剂、信息素扩散器、舒缓焦虑的包裹、行为训练技巧以及互动玩具,帮助宠物应对分离、噪音、移动和陌生环境等诱因。透过同时解决焦虑的生理和心理层面,我们旨在改善宠物的整体健康状况,促进宠物与饲主之间建立更健康的联繫,并在各种环境中为动物创造一个更平衡、无压力的生活环境。
宠物饲养量增加
随着越来越多的家庭将宠物视为家庭成员,对缓解宠物焦虑解决方案的需求也稳定成长。随着首次养宠者和城市居民的增加,动物面临孤独、室内禁闭和过度刺激等压力。这种转变促使饲主寻求可靠的工具,从营养补充品到智慧镇静设备,以帮助稳定宠物的情绪。随着人们责任感的增强,市场受益于持续的、长期的宠物健康维护投入,而非仅仅寻求短期解决方案,这推动了市场扩张。
高成本
儘管人们的意识日益增强,高品质镇静补充剂、行为疗法和临床治疗的高成本仍然是其广泛应用的一大障碍。预算限制使得许多饲主无法负担重复购买或更高阶的焦虑管理方案。兽医推荐的解决方案虽然有效,但往往价格不菲。这种成本壁垒减缓了价格敏感地区的市场渗透率,并阻碍了人们的持续使用。在价格可负担性提升之前,市场将继续面临挑战,因为消费者往往更倾向于优先考虑基本护理而非专业的焦虑管理。
宠物心理健康意识
人们对宠物心理健康的日益关注为市场成长带来了巨大机会。随着饲主逐渐意识到焦虑是一种真正的健康问题,从情绪支持补充剂到互动式益智玩具,对预防性和整体性护理的需求也日益增长。社群媒体、兽医宣传活动以及生活方式的改变,使宠物心理健康成为主流话题,并促进了负责任的宠物饲养。这种文化转变催生了创新、个人化解决方案和技术赋能的监测,使品牌能够透过基于科学的长期健康产品建立客户忠诚度。
监管挑战
监管的复杂性为市场蒙上了一层阴影,尤其是在镇静补充剂、费洛蒙产品和具有疗效宣称的产品领域。严格的区域合规性、临床检验和清晰的检验要求推高了成本,延缓了产品上市速度。未经证实的健康宣称会带来罚款、产品召回和消费者信任度下降的风险。膳食补充剂和宠物治疗产品监管法规的不断变化迫使企业持续调整配方和文件,这阻碍了其全球扩张,并减缓了创新週期。
疫情大大改变了宠物焦虑的趋势。封锁措施加强了人与宠物之间的联繫,但也使宠物更依赖主人的持续陪伴。疫情后的生活常态化,包括重返办公室、旅行和繁忙的日程安排,导致了宠物分离焦虑的普遍存在,从而推动了对安抚产品和训练方案的需求。供应链中断影响了产品的供应,而远端兽医服务的兴起则增加了饲主对个人化支援的偏好。
预计在预测期内,犬类细分市场将占据最大的市场份额。
预计在预测期内,犬类市场将占据最大的市场份额,因为与其他宠物相比,犬类更容易出现分离焦虑、噪音恐惧症以及因旅行和陌生环境而产生的压力。全球犬主数量的增长以及饲主对宠物行为健康的意识提升,推动了对镇静补充剂、信息素注入器和抗焦虑裹敷等产品的需求。种类繁多的犬类专用产品确保了该市场在该领域的主导地位。
预计在预测期内,兽医院板块的复合年增长率将最高。
由于宠物主人越来越依赖专业护理来诊断和治疗宠物焦虑症,预计在预测期内,兽医诊所领域将实现最高的成长率。兽医诊所提供了一个值得信赖的环境,饲主可以寻求专家建议、检验的治疗方法和安全的产品推荐。人们对动物心理健康的意识提升以及行为训练计画在兽医服务中的应用,将进一步推动市场需求。随着饲主越来越重视专业指导,兽医诊所正成为焦虑症管理解决方案成长最快的通路。
由于中国、印度和日本等国家宠物拥有率不断上升,预计亚太地区将在整个预测期内占据最大的市场份额。快速的都市化、生活方式的改变以及可支配收入的增加,正推动着伴侣动物(尤其是犬猫)饲养量的成长。人们对宠物福利意识的提高以及电子商务平台的扩张,使得宠物焦虑管理解决方案更容易获得。区域製造商受益于成本效益高的生产模式和强劲的市场需求,预计这将有助于亚太地区在整个预测期内保持其市场主导地位。
在预测期内,北美预计将实现最高的复合年增长率,这主要得益于其先进的兽医基础设施和消费者对动物心理健康的高度关注。宠物护理方面的高额支出以及创新舒缓产品的广泛应用正在推动这一成长。疫情后分离焦虑症病例的增加以及消费者对实证天然解决方案日益增长的需求,进一步加速了这些产品的普及。北美正崛起为成长最快的区域市场,这得益于其强大的分销网络、法规结构以及重视宠物福祉的文化。
According to Stratistics MRC, the Global Pet Anxiety Solutions Market is accounted for $2.0 billion in 2025 and is expected to reach $3.1 billion by 2032 growing at a CAGR of 6.3% during the forecast period. Pet Anxiety Solutions refer to a range of products, therapies, and interventions designed to alleviate stress, fear, and nervous behaviors in animals, particularly companion pets such as dogs and cats. These solutions encompass calming supplements, pheromone diffusers, anxiety wraps, behavioral training techniques, and interactive toys that help pets cope with triggers like separation, loud noises, travel, or unfamiliar environments. By addressing both physical and emotional aspects of anxiety, they aim to improve pets' overall well-being, foster healthier bonds with owners, and create a more balanced, stress-free living environment for animals in diverse settings.
Rising Pet Ownership
Rising pet ownership is fueling steady demand for anxiety-relief solutions as households increasingly treat pets as family members. With more first-time pet parents and growing urban lifestyles, animals face triggers like isolation, indoor confinement, and overstimulation. This shift is pushing owners to seek reliable tools-from supplements to smart-calming devices-to keep pets grounded. As responsibility deepens the market benefits from consistent, long-term spending on well-being rather than short-term fixes. Thus, it drives market expansion.
High Costs
Despite growing awareness, the high cost of premium calming supplements, behavior therapies, and clinical treatments limits broader adoption. Many pet parents hesitate to invest in repeat-purchase products or advanced anxiety interventions due to tight budgets. Veterinary-recommended solutions, though effective, often involve significant fees. This cost barrier slows market penetration in price-sensitive regions and prevents consistent adherence. Until affordability improves, the market must contend with hesitant buyers who prioritize only essential care over specialized anxiety management.
Awareness of Pet Mental Health
Expanding awareness of pet mental health is opening strong opportunities for market growth. As owners recognize anxiety as a genuine condition, demand rises for preventive and holistic care-ranging from emotional-support supplements to interactive enrichment tools. Social media, veterinary campaigns, and lifestyle shifts have made mental well-being a mainstream conversation, encouraging responsible pet parenting. This cultural shift invites innovation, personalized solutions, and tech-enabled monitoring, allowing brands to build loyalty through science-based, long-term wellness products.
Regulatory Challenges
Regulatory complexities loom over the market, especially for calming supplements, pheromone products, and therapeutic claims. Different regions require strict compliance, clinical validation, and clear labeling, which raises costs and slows product rollouts. Any unverified health claims risk penalties, product recalls, or reduced consumer trust. The evolving rules around nutraceuticals and pet therapeutics force companies to constantly adjust formulations and documentation. This landscape creates hurdles for global expansion and delays innovation cycles.
The pandemic reshaped pet anxiety trends dramatically. While lockdowns strengthened human-pet bonds, pets became dependent on constant companionship. Post-pandemic routines-returning to offices, travel, and busy schedules-triggered widespread separation anxiety, boosting demand for calming aids and training solutions. Supply-chain disruptions affected product availability, but increased tele-veterinary services encouraged owners to seek tailored support.
The dogs segment is expected to be the largest during the forecast period
The dogs segment is expected to account for the largest market share during the forecast period, as dogs are more prone to separation anxiety, noise phobias, and stress from travel or unfamiliar environments compared to other pets. Rising global dog ownership, coupled with increased awareness among pet parents about behavioral health, drives demand for calming supplements, pheromone diffusers, and anxiety wraps. The availability of diverse dog-specific products ensures this segment maintains its leadership position.
The veterinary hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary hospitals segment is predicted to witness the highest growth rate, due to growing reliance on professional care for diagnosing and managing pet anxiety. Veterinary hospitals provide trusted environments where pet owners seek expert advice, validated therapies, and safe product recommendations. Rising awareness of animal mental health and the integration of behavioral training programs within veterinary services further boost demand. As pet owners increasingly prioritize professional guidance, veterinary hospitals emerge as the fastest-growing distribution channel for anxiety solutions.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, owing to rising pet ownership in countries such as China, India, and Japan. Rapid urbanization, changing lifestyles, and growing disposable incomes have led to increased adoption of companion animals, particularly dogs and cats. Heightened awareness of pet well-being and the expansion of e-commerce platforms make anxiety solutions more accessible. Regional manufacturers benefit from cost-effective production and strong demand, ensuring Asia Pacific's dominance throughout the forecast period.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to advanced veterinary infrastructure and strong consumer awareness of animal mental health. The region's high spending on pet care, combined with widespread adoption of innovative calming products, drives growth. Rising cases of separation anxiety post-pandemic and increasing demand for natural, science-backed solutions further accelerate adoption. With robust distribution networks, regulatory frameworks, and a culture of prioritizing pet wellness, North America emerges as the fastest-growing regional market.
Key players in the market
Some of the key players in Pet Anxiety Solutions Market include Ceva Sante Animale, Zoetis, Elanco, Vetoquinol, Virbac, Nestle Purina, Mars Petcare, Nutramax Laboratories, Zesty Paws, Pet Naturals of Vermont, NaturVet, ThunderShirt, PetIQ, Boehringer Ingelheim and VetriScience.
In July 2025, Odie Pet Insurance is partnering with Nestle Purina PetCare to embed Petivity by Purina into its underwriting and wellness plans, using pet-health data and smart devices to reward preventive care and reimburse Petivity tool costs - shifting insurance from reactive to proactive.
In June 2025, Nestle Purina is rolling out fully recyclable PET canisters for its Friskies Party Mix cat treats, eliminating over 500 tonnes of virgin plastic annually. Meanwhile, Amcor has launched mono-material pouches, and A'Peel introduced a clean-peel label - all boosting circularity.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.